OTC Markets OTCPK - Delayed Quote USD

Oryzon Genomics S.A. (ORYZF)

Compare
1.9300 -0.5200 (-21.22%)
At close: October 18 at 4:00 PM EDT
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Cost of Revenue
-10,530.2960
-13,947.9140
-15,234.1600
-9,869.5340
-8,994.7650
--
Gross Profit
10,530.2960
13,947.9140
15,234.1600
9,869.5340
8,994.7650
--
Operating Expense
15,012.7750
18,497.1070
20,724.0700
16,876.0760
13,284.4040
--
Operating Income
-4,482.4790
-4,549.1930
-5,489.9100
-7,006.5420
-4,289.6390
--
Net Non Operating Interest Income Expense
-1,277.6320
-1,859.5710
-1,107.6540
-449.8490
-468.9610
--
Pretax Income
-5,750.1170
-6,104.0260
-6,556.5060
-7,179.8710
-4,778.7300
--
Tax Provision
-1,925.2440
-2,751.0830
-2,325.1030
-2,492.9010
-1,379.1730
--
Net Income Common Stockholders
-3,824.8730
-3,352.9430
-4,231.4030
-4,686.9700
-3,399.5570
--
Diluted NI Available to Com Stockholders
-3,824.8730
-3,352.9430
-4,231.4030
-4,686.9700
-3,399.5570
--
Basic EPS
-0.06
-0.06
-0.08
-0.09
-0.06
--
Diluted EPS
-0.06
-0.06
-0.08
-0.09
-0.06
--
Basic Average Shares
62,941.2750
60,879.3280
56,042.4200
52,761.5540
52,761.5540
--
Diluted Average Shares
62,941.2750
60,879.3280
56,042.4200
52,761.5540
52,761.5540
--
Total Operating Income as Reported
-4,482.4790
-4,549.1930
-5,489.9100
-7,010.5650
-4,294.2230
--
Total Expenses
4,482.4790
4,549.1930
5,489.9100
7,006.5420
4,289.6390
--
Net Income from Continuing & Discontinued Operation
-3,824.8730
-3,352.9430
-4,231.4030
-4,686.9700
-3,399.5570
--
Normalized Income
-3,863.8201
-3,506.3968
-4,105.4917
-4,684.5266
-3,396.2960
--
Interest Income
88.7630
33.9680
11.5810
5.7230
0.1270
--
Interest Expense
1,366.3950
1,893.5390
1,119.2350
455.5720
469.0880
--
Net Interest Income
-1,277.6320
-1,859.5710
-1,107.6540
-449.8490
-468.9610
--
EBIT
-4,383.7220
-4,210.4870
-5,437.2710
-6,724.2990
-4,309.6420
--
EBITDA
-4,233.6960
-4,057.6030
-5,270.6090
-6,579.9680
-4,164.5910
--
Reconciled Cost of Revenue
-10,530.2960
-13,947.9140
-15,234.1600
-9,869.5340
-8,994.7650
--
Reconciled Depreciation
150.0260
152.8840
166.6620
144.3310
145.0510
--
Net Income from Continuing Operation Net Minority Interest
-3,824.8730
-3,352.9430
-4,231.4030
-4,686.9700
-3,399.5570
--
Total Unusual Items Excluding Goodwill
58.5510
204.6050
-195.0980
-3.7430
-4.5840
--
Total Unusual Items
58.5510
204.6050
-195.0980
-3.7430
-4.5840
--
Normalized EBITDA
-4,292.2470
-4,262.2080
-5,075.5110
-6,576.2250
-4,160.0070
--
Tax Rate for Calcs
0.0003
0.0003
0.0004
0.0003
0.0003
--
Tax Effect of Unusual Items
19.6039
51.1513
-69.1867
-1.2996
-1.3230
--
12/31/2019 - 12/15/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers